Clinical Trial Update: A 16 Week Study Evaluating Levetiracetam in the Treatment of Post Herpetic Neuralgia (PHN) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating levetiracetam for postherpetic neuralgia has completed. The update provides status but does not report efficacy or safety results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postherpetic Neuralgia

Drugs mentioned

• LEVETIRACETAM (levetiracetam)

Snippet

Sponsor: UCB Pharma | Conditions: Neuralgia, Postherpetic | Phase 2 | Status: COMPLETED